Joanna Socha

1 month ago | ionanalytics.com | Joanna Socha |Lucinda Guthrie |Laura Larghi |Katka Krosnar

To mark International Women’s Day, the women of ION Analytics, including reporters and analysts at Debtwire, Mergermarket, Dealreporter, Cybersecurity Law Report, Hedge Fund Law Report, and Anti-Corruption Report have interviewed outstanding women in their respective jurisdictions and fields. It is our honor to highlight these women and their accomplishments and contributions to their industries and share some of their insights and perspectives.

Nov 4, 2024 | ionanalytics.com | Joanna Socha |Samantha Shaji |Lloyd Vassell

Casino Group sells GreenYellow stake for EUR 46m, demonstrating growing interestSmart grid tech and energy management crucial in Europe’s energy transitionPE funds and VCs to play key role in sector’s growth, with EUR 1.5bn deal volume in 2022Energy efficiency is becoming a core part of Europe’s energy transition.

Jul 22, 2024 | ionanalytics.com | Joanna Socha |Santosh Shetty |Lloyd Vassell

A global pandemic, supply chain disruptions, a European land war, inflation, and increased debt costs have all challenged financial markets around the world in recent years. And the opening shots of a trade war between the West and China could create even more turbulence in the years ahead. Luckily, though, 3D printing (or additive manufacturing) should be able to absorb some of the shock, while creating an opportunity for dealmakers in Europe, the Middle East and Africa (EMEA) and further afield.

Jul 8, 2024 | ionanalytics.com | Joanna Socha |Santosh Shetty |Lloyd Vassell

Going to therapy has slowly been becoming more mainstream for years. As a result of this secular trend, ticket sizes in deals involving European mental health clinics and psychotherapy services have also been creeping higher. “On the one hand, we see mental health services increasing exponentially; on the other, we can observe increasing destigmatisation of the treatments,” Steven Hacking, Partner at Eversheds Sutherland said.

Jun 17, 2024 | ionanalytics.com | Joanna Socha |Santosh Shetty |Lloyd Vassell

Although chemotherapy can be a very successful therapy for cancer, it takes a scorched Earth approach, killing healthy cells alongside tumours. Medical researchers have dreamt of finding a “magic bullet” that will just target cancerous cells since at least 1900. Antibody-drug conjugates (ADCs) – complex molecules based on a biologically active cytotoxic (anticancer) payload – look like the best shot within oncology dealmaking.